Bliss Kelly's Form 4 filing
Teladoc Health, Inc. (TDOC) · filed Mar 3, 2026
- Accession no.
- 0002036989-26-000002
- Filed
- Mar 3, 2026
- Trade date
- Feb 27-Mar 2, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 7 derivative transactions. Open-market sales total $136.4K. It was filed 4 days after the trade.
This filing was later replaced by the amendment 0002036989-26-000004 (Mar 12, 2026). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bliss KellyCIK 0002036989 | Officer (President, U.S. Group Health) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Common Stock | MOption exerciseAcquired | +3,488 | –F1 | – | 63,542 | Direct | |
| Feb 27, 2026 | Common Stock | MOption exerciseAcquired | +4,858 | –F1 | – | 68,400 | Direct | |
| Feb 27, 2026 | Common Stock | MOption exerciseAcquired | +36,610 | –F1 | – | 105,010 | Direct | |
| Feb 27, 2026 | Common Stock | MOption exerciseAcquired | +1,186 | –F2 | – | 106,196 | Direct | |
| Feb 27, 2026 | Common Stock | MOption exerciseAcquired | +5,198 | –F2 | – | 111,394 | Direct | |
| Mar 2, 2026 | Common Stock | SSaleDisposed | −26,647 | $5.12 | −$136,432.64 | 84,747 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Common Stock | MOption exerciseDisposed | −3,488 | $0.00 | $0 | 0 | Direct | |
| Feb 27, 2026 | Common Stock | MOption exerciseDisposed | −4,858 | $0.00 | $0 | 19,435 | Direct | |
| Feb 27, 2026 | Common Stock | MOption exerciseDisposed | −36,610 | $0.00 | $0 | 73,222 | Direct | |
| Feb 27, 2026 | Common Stock | MOption exerciseDisposed | −1,186 | $0.00 | $0 | 0 | Direct | |
| Feb 27, 2026 | Common Stock | AGrant or awardAcquired | +27,458 | $0.00 | $0 | 27,458 | Direct | |
| Feb 27, 2026 | Common Stock | MOption exerciseDisposed | −5,198 | $0.00 | $0 | 22,260 | Direct | |
| Mar 1, 2026 | Common Stock | AGrant or awardAcquired | +181,661 | $0.00 | $0 | 181,661 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Referenced by the price of 3 transactions in Table I.
- F2
Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
Referenced by the price of 2 transactions in Table I.